Primary Immunodeficiency Disease News

Dupilumab was safe and effective in treating a group of six children and young adults with inborn errors of immunity and moderate to severe atopic dermatitis, according to a study published in Pediatric Allergy and Immunology.

Patients infected with SARS-CoV-2 saw a reduction of immune cells and a change in growth factor patterns in their blood 10 months after infection, according to a study published in Allergy.

Patients infected with SARS-CoV-2 showed signs of reduced immune cells and a change in growth factor patterns in their blood 10 months after infection, according to a study published in Allergy.

There are more than 450 monogenetic immune deficiencies. While many of these rare conditions have similar hallmarks, it is crucial for clinicians to differentiate between them.

Healio compiled the most-read news in allergy, asthma and immunology posted in May.

Healio has compiled April’s most-read news in asthma and allergy.

The FDA has approved mavorixafor for treating warts, hypogammaglobulinemia, infections and myelokathexis — or WHIM — syndrome, a rare and chronic primary immunodeficiency, according to a press release from X4 Pharmaceuticals.

The effects of climate change break down epithelial barriers, enabling pollutants and other materials to penetrate the body and trigger or exacerbate autoimmune diseases, according to a review published in Frontiers in Science.

WASHINGTON — Genetic testing can provide answers about children who may have primary immunodeficiencies when antibody and cell testing meet their limits, according to a speaker at the Academy of Allergy, Asthma & Immunology Annual Meeting.